Publicaciones (435) Publicaciones en las que ha participado algún/a investigador/a

2021

  1. Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias

    Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-31

  2. Post-Transplant Diabetes Mellitus and Prediabetes in Renal Transplant Recipients: An Update

    Nephron

  3. Beta-cell dysfunction induced by tacrolimus: A way to explain type 2 diabetes?

    International Journal of Molecular Sciences, Vol. 22, Núm. 19

  4. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients

    Biochemical and Biophysical Research Communications, Vol. 543, pp. 45-49

  5. Structural basis of the pleiotropic and specific phenotypic consequences of missense mutations in the multifunctional NAD(P)H:quinone oxidoreductase 1 and their pharmacological rescue

    Redox Biology, Vol. 46

  6. Impact of hla mismatching on early subclinical inflammation in low‐immunological‐risk kidney transplant recipients

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  7. High Expression of FOXP2 Is Associated with Worse Prognosis in Glioblastoma

    World Neurosurgery, Vol. 150, pp. e253-e278

  8. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients

    Kidney International, Vol. 99, Núm. 3, pp. 671-685

  9. Exercise and Prediabetes after Renal Transplantation (EXPRED): Protocol Description

    Nephron, Vol. 145, Núm. 1, pp. 55-62

  10. Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria

    Cell Reports, Vol. 36, Núm. 8

  11. Clinical relevance of corticosteroid withdrawal on graft histological lesions in low-immunological-risk kidney transplant patients

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  12. ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer

    Oncogene, Vol. 40, Núm. 16, pp. 2923-2935